MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm15041539

Медицинская библиотека · Journal of clinical medicine · 2026

Long-Term Metabolic Remission and Predictive Factors After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in an Asian Population.

Sakolprakaikit Kanittha, Yolsuriyanwong Kamthorn, Cheewatanakornkul Siripong, Wangkulangkul Piyanun, Leelawattana Rattana, Saelue Pirun, Promchan Darawan, Bualoy Praisuda

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objective

Bariatric surgery is an established treatment for individuals with severe obesity, providing sustained weight loss and improvement in obesity-related comorbidities. However, evidence on long-term outcomes and predictors of metabolic resolution, particularly among Asian populations, remains limited. We aimed to evaluate metabolic outcomes after bariatric surgery and identify predictive factors associated with remission.

Methods

We retrospectively reviewed the data of 581 patients who underwent laparoscopic sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at a tertiary care center between January 2012 and December 2022. Surgical techniques, postoperative follow-up, and baseline characteristics were recorded. Remission and improvement of metabolic comorbidities were assessed during 1-5 years of follow-up. Predictive factors were analyzed, and remission rates between SG and RYGB were compared using propensity score matching.

Results

A total of 154 (26.5%) individuals had type 2 diabetes mellitus (T2DM), 162 (27.8%) hypertension (HT), 173 (29.7%) dyslipidemia (DLP), and 407 (70.0%) metabolic syndrome (MetS). Remission occurred in 79.1% of individuals with T2DM, 36.0% with HT, 33.9% with DLP, and 79.6% with MetS. Predictive factors included T2DM duration < 3 years, younger age for HT and DLP remission, male sex, body mass index < 43 kg/m2, and fasting blood glucose level < 126 mg/dL for MetS. RYGB achieved higher remission of DLP than did SG, whereas other outcomes were comparable.

Conclusions

Bariatric surgery effectively improves metabolic comorbidities, and several predictive factors influence outcomes. RYGB resulted in superior remission of DLP, while other metabolic outcomes were comparable between the two procedures.

Для цитирования: Sakolprakaikit Kanittha, Yolsuriyanwong Kamthorn, Cheewatanakornkul Siripong, Wangkulangkul Piyanun, Leelawattana Rattana, Saelue Pirun, Promchan Darawan, Bualoy Praisuda. Long-Term Metabolic Remission and Predictive Factors After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in an Asian Population.. Journal of clinical medicine. 2026. DOI: 10.3390/jcm15041539.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.